Kenkodo-Mining of metabolomic profiles

Molecular Biomarkers & Diagnosis

ISSN: 2155-9929

Open Access

Kenkodo-Mining of metabolomic profiles

7th International Conference and Expo on Molecular & Cancer Biomarkers

September 15-16, 2016 Berlin, Germany

Josephine Worseck

Metabolomic Discoveries GmbH, Germany

Scientific Tracks Abstracts: J Mol Biomark Diagn

Abstract :

The Kenkodo Kit -offered by the German biotech company Metabolomic Discoveries- reveals exciting insights into the relationship between lifestyle and biochemical blood composition. Kenkodo is the first personalized metabolism analysis that combines personal lifestyle data with cutting-edge blood analytics. Users benefit from an easy and convenient blood sampling at home and insights that help to optimize well-being and to avoid diseases. The Kenkodo companion app integrates, tracks and visualizes the impact of human lifestyle in relationship to their metabolism with the aim to improve personal health outcomes. Metabolomic Discoveries GmbH is a leading company in the field of diagnostic biomarker research. Using highthroughput GC/MS and LC/MS combined with bioinformatic methods, Metabolomic Discoveries identifies and quantifies endogenous metabolites in body fluid or tissue samples and develops them into powerful biomarkers.

Biography :

Josephine Worseck is the Head of Business Development at Metabolomic Discoveries and has a scientific background in the field of Systems Biology. Her research at the Max Planck Institute for Molecular Genetics has been focused on the integrative analysis of data derived from high-throughput ‘omics technologies. After six years of applied science, she is now responsible for the consulting of scientists who want to resolve complex biological questions by metabolomics.


Google Scholar citation report
Citations: 2054

Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report

Molecular Biomarkers & Diagnosis peer review process verified at publons

Indexed In

arrow_upward arrow_upward